ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.

Saeed Rafii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.